In this episode of the Insight Network podcast, ATAI’s Allan Malievsky chats with Dr. Matthew W. Johnson, one of the the world’s most published psychedelic medicine researchers and associate director of the renowned Johns Hopkins Psychedelic Research Unit.
In this wide ranging discussion, Dr. Johnson touches on everything from how certain drugs affect our decision making, time horizons, and reward sensitivity, to the intersection of religious traditions and clinical practice. Whether you’re an entrepreneur, researcher, or advocate, Dr. Johnson offers powerful insights into the future of psychedelic medicine.
If you can, please donate to the Johns Hopkins Psychedelic Research Unit here.